Skip to main content
. 2016 May 23;16:102. doi: 10.1186/s12872-016-0259-6

Table 2.

Factors tested as predictors of lack of change in the d-ROMs level 2 weeks after AMI

Univariate analysis Multivariate analysis
Factor OR (95 % CI) p value OR (95 % CI) p value
Age 1.01 (0.95–1.07) 0.677
Sex 1.50 (0.31–10.87) 0.629
BMI 1.09 (0.89–1.35) 0.396
Diabetes mellitus 3.05 (1.07–9.34) 0.037 3.33 (1.15–10.48) 0.027
Fasting glucose level 1.01 (0.98–1.05) 0.363
2 h OGTT glucose level 1.02 (1.00–1.03) 0.032 1.02 (1.00–1.04) 0.098
HOMA-IR 1.10 (0.79–1.51) 0.570
eGFR 1.00 (0.98–1.04) 0.675
CPK (maximum) 1.00 (1.00–1.00) 0.354
LDL cholesterol 0.99 (0.97–1.01) 0.424
hs-CRP 1.05 (0.48–2.13) 0.904
NT-proBNP 1.00 (1.00–1.00) 0.147
Ca channel blocker 0.18 (0.01–1.11) 0.122
Beta blocker 3.35 (0.84–17.03) 0.105
ACE-I/ARB 0.38 (0.02–3.38) 0.428
Nitrate 0.20 (0.05–0.83) 0.028 0.36 (0.07–1.89) 0.216
Statin 0.39 (0.09–1.60) 0.180

Multivariate logistic regression analysis showed the presence of diabetes mellitus was a significant predictor of no change in the d-ROMs level by 2 weeks after AMI. d-ROMs derivatives of reactive oxygen metabolites, AMI acute myocardial infarction, OR odds ratio, CI confidence interval, BMI body mass index, OGTT oral glucose tolerance test, HOMA-IR homeostatic model assessment-insulin resistance, eGFR estimated glomerular filtration rate, CPK creatine phosphokinase, LDL low density lipoprotein, hs-CRP high-sensitivity C-reactive protein, NT-proBNP N-terminal prohormone of brain natriuretic peptide, ACE-I angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker